ADVANCED ALVEOLAR SOFT PART SARCOMA

Clinical trials for ADVANCED ALVEOLAR SOFT PART SARCOMA explained in plain language.

Never miss a new study

Get alerted when new ADVANCED ALVEOLAR SOFT PART SARCOMA trials appear

Sign up with your email to follow new studies for ADVANCED ALVEOLAR SOFT PART SARCOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1

New hope for rare cancer: Two-Drug attack on tough sarcoma

Disease control Recruiting now

This study is testing if a combination of two drugs, atezolizumab and selinexor, can shrink tumors in patients with advanced alveolar soft part sarcoma, a rare and difficult-to-treat cancer. The trial is for patients whose cancer has continued to grow despite prior immunotherapy.…

Matched conditions: ADVANCED ALVEOLAR SOFT PART SARCOMA

Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control

Last updated Mar 23, 2026 15:14 UTC

ADVANCED ALVEOLAR SOFT PART SARCOMA

Get alerted when new ADVANCED ALVEOLAR SOFT PART SARCOMA trials appear

New hope for rare cancer: Two-Drug attack on tough sarcoma